Modular implant for repairing a segmental long bone defect
A modular cellular implant with interchangeable titanium alloy modules addresses the challenge of long bone defects by providing immediate, stable, and customizable repair, optimizing osteogenesis and preventing inflammation without preoperative planning.
Patent Information
- Application Number
- PCT/RU2026/050126
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-12
- Filing Date
- 2026-05-05
- Publication Date
- 2026-11-19
AI Technical Summary
Existing methods for replacing long bone defects require extensive preoperative planning and customization, limiting their applicability to patients with varying defect sizes and locations, and prolong treatment duration, mobility, and financial burden.
A modular cellular implant composed of interchangeable modules made of titanium alloy, allowing intraoperative assembly and adjustment to fit various defect sizes, with a bioactive coating and intramedullary fixation for immediate defect replacement and osteogenesis.
Enables rapid, stable, and customizable bone defect repair without preoperative planning, optimizing osteogenesis and preventing inflammation, suitable for diverse bone defects of any etiology.
Smart Images

Figure RU2026050126_19112026_PF_FP_ABST
Abstract
Description
MODULAR IMPLANT FOR REPLACING CIRCULAR DEFECTS IN LONG BONE Field of technology
[0001] The invention relates to medicine, specifically to implantable devices for replacing circular defects of long bones of any etiology. It can be used in traumatology, reconstructive surgery, military field surgery, and disaster medicine, in providing assistance to victims by replacing the diaphysis of a long bone while restoring its supporting function. This application is a continuation of application RU 2025112263, filed May 12, 2025, which is incorporated herein in its entirety by this reference. State of the art
[0002] The long tubular bones include the femur, tibia, and fibula; the humerus, ulna, and radius. Fractures of the long tubular bones have become a leading cause of injury in recent decades. The loss of the bone shaft occurs as a result of trauma, pathology, or surgery. The number of people injured in traffic accidents, conflicts, disasters, and accidents resulting in shaft defects of the long bones necessitates the search for new surgical treatment techniques.
[0003] A known method for filling a long tubular bone defect is the Ilizarov method (source [1]: SU 313 533). This method involves performing a bone osteotomy and graduated displacement of the isolated fragment, forming a regenerate until the defect is completely filled, followed by fixation using a compression-distraction apparatus. Ilizarov transosseous compression-distraction osteosynthesis is used to treat complex fractures, lengthen bones, correct deformities, and restore limb function. Defect filling is performed using a compression-distraction apparatus, which is used to gradually move the bone fragment, while the space between the fragments is filled with regenerate, which is transformed into full-fledged bone tissue during fixation. The Ilizarov method allows for the formation of natural bone tissue in the defect area and ensures the anatomical integrity of the bone and its supporting function.
[0004] However, the rate of bone regeneration, given the technologies used today, requires osteosynthesis using the method described [1] to last several months. During this time, the patient wears a compression-distraction apparatus on the limb, limiting mobility and work capacity, which is a disadvantage for many. Furthermore, the length of treatment increases the financial burden on the healthcare system, which, in the current economic climate, is also considered a disadvantage.
[0005] It is known that the replacement of tubular bone defects can be achieved using implants and prostheses that replace missing bone tissue.
[0006] A method for treating long bone defects (source [2]: RU 2839033) caused by gunshot wounds using 3D implants is known. A cement spacer containing antibiotics is placed into the bone defect. After the spacer is removed, a titanium mesh 3D implant, matching the configuration of the bone defect and impregnated with cancellous bone, is inserted into the defect. The 3D implant is fixed by intramedullary insertion of a rod covered with a custom-made mantle of bone cement containing antibiotics.
[0007] Reliable fixation of 3D implants [2] is ensured by the use of a transosseous compression-distraction apparatus, such as the Ilizarov device. This 3D implant [2] is a custom-fabricated titanium mesh structure, which is fixed with a standard metal locking rod. Manufacturing a 3D implant requires time before surgery, meaning it is only suitable for planned procedures performed on a specific patient. Manufacturing a 3D implant requires a strictly personalized approach, which precludes the replacement of circular defects of long bones of any etiology, especially when treating patients with various defects, varying in location, geometric characteristics (length, shape), and other parameters.
[0008] A combined implant for replacing a localized defect in the diaphysis of a tubular bone is known (source [3]: patent RU 193394), consisting of an autograft obtained from a fragment of the diaphysis of the patient's fibula and an artificial material. The autograft contains a sleeve equipped with longitudinal through-channels made of polytetrafluoroethylene. The sleeve is shorter than the autograft, and the proximal and distal ends of the autograft protrude for placement in the medullary canal of the bone.
[0009] A combined implant [3] requires the collection of the patient's fibula diaphysis and the manufacture of an implant, which requires an exclusively personalized approach and does not allow for the replacement of circular defects of long bones of any etiology, when providing mass assistance to patients with various defects that differ in localization, geometric (length, shape) and other parameters.
[0010] A personalized bioactive structured implant for replacing a circular defect in the long bones of the extremities (source [4]: patent RU 173381) is manufactured using additive technology through layer-by-layer material buildup according to the shape, size, and structure specified by a three-dimensional mathematical model constructed based on a three-dimensional mathematical model of bone obtained from computed tomography, in the form of a solid. The geometric shape of the solid corresponds to the geometric shape of normal, anatomically intact, healthy bone, which should be located in the defect area. The longitudinal and transverse dimensions of the solid correspond to the dimensions of the diastasis. It is equipped with support rims at both ends.
[0011] A cellular cylindrical bioactive implant for replacing circular defects of tubular bones is known (source [5]: patent RU 171823). It is manufactured using additive technology by layer-by-layer build-up of material according to the shape, size, and structure specified by a three-dimensional mathematical model. It is in the form of a cylinder, equipped with shells at the ends, the dimensions of the cylinder correspond to the dimensions of the diastasis, the internal diameter of each shell corresponds to the largest external transverse dimension of the bone fragment in the defect area, contains a network of similar longitudinal and transverse through-channels in the form of cells, a network of pores, covered with a biologically active layer, radial holes are made on the shells.
[0012] Structured titanium implants [4;5] are custom-made and fabricated upon patient admission. They are not suitable for variously sized tubular bone defects due to the discrepancy between their geometric parameters (shape, size) and the geometric parameters of the tubular bones at the site of implantation in any given patient (a patient who actually requires defect replacement, but no preliminary surgical planning has been performed). A personalized approach requires preliminary preparation and information about the patient, as well as the location, size, and shape of the defect, which precludes mass defect replacement in patients with defects of varying parameters. The use of these implants complicates the manufacturing process and requires costly logistical support for production and use.The implants require the use of Direct Metal Selective Laser Melting (SLM) technology and access to the appropriate equipment. They do not accommodate an intramedullary nail for fixation. Furthermore, the junction adaptation process requires trimming the ends of the bone fragments at a precise 90° angle to the segment axis, which leads to significant bone loss and requires specialized instrumentation.
[0013] Thus, the problem of simultaneously filling a long bone diaphysis defect with restoration of support function exists in the treatment of random patients admitted for treatment with defects of varying sizes for whom preoperative planning has not been performed. The problem of filling extensive bone defects remains pressing. To address these challenges, additive manufacturing technologies are currently used to manufacture medical devices from various materials with a specified shape and surface structure, including those with bioactive properties. However, their use is only possible in high-tech centers equipped with the necessary equipment.
[0014] A modular cellular implant for replacing a circular defect of a long bone, characterized in that it contains a first end module, at least one intermediate module and a second end module; the first end module is made in the form of a body equipped on one side with a surface intended for contact with the first bone fragment, made convex or concave spherical or conical, and on the opposite side with a surface intended for mating with the intermediate module; the second end module is made in the form of a body equipped on one side with a surface intended for contact with the second bone fragment, made convex or concave spherical or conical, and on the opposite side with a surface intended for mating with the intermediate module;the intermediate module is made in the form of a body equipped on opposite sides with surfaces intended for mating with the first and second end modules and / or intermediate modules; each module is equipped with a through axial channel made with the possibility of forming a common channel when connecting the modules for inserting an intramedullary fixator; the mating surfaces of the modules have a geometric shape that excludes transverse displacement of the modules relative to each other; the modules are made of a non-biodegradable metallic material possessing biocompatibility, selected from: titanium or its alloy, for example from the VT-6 alloy or from steel.
[0015] The implant is assembled intraoperatively from modules after resection and adaptation of the bone fragment ends. This allows for the restoration of circular bone defects of various sizes and causes, providing stable fixation, optimizing osteogenesis, preventing inflammation, and even treating osteomyelitis. The implant set consists of end and intermediate modules. The end modules, on the side adjacent to the bone, have a convex or concave spherical surface. On the other side, there is a node for mating with the intermediate module or with each other. The intermediate modules also have nodes at their ends for mating with each other or with the end modules. The node ensures tight contact between the modules, preventing displacement relative to each other.
[0016] This ensures immediate replacement of the bone defect with an implant. Filling a circular defect in a long bone of any length and ensuring weight-bearing ability of the limb using a modular implant is possible without the need for extensive preoperative planning. Furthermore, the use of a modular implant with an intramedullary nail improves the reliability of fixation and dynamic compression in the implant-bone interface, improving the stability of the bone fragments throughout the healing process. The essence of the invention
[0017] The technical challenge is to simultaneously repair a diaphyseal defect of arbitrary length (extent), unknown in advance, while restoring the supporting function of the long bone. This is achieved by using a universal implant that allows for discrete length adjustments, tailoring the length to the defect length, to repair defects of various sizes in any long bone. This allows for intraoperative length selection from a set of standard modules, eliminating the need for preoperative fabrication of a customized implant.
[0018] The technical result consists in the one-stage restoration of a circular defect of a long bone of arbitrary length and ensuring the support capacity of the limb. Figure 1
[0019] - general diagram, modular implant between bone fragments, in section;
[0020] - general diagram, modular implant between bone fragments, in section, contains three intermediate modules;
[0021] - general diagram, modular implant between bone fragments, in section, contains two intermediate modules;
[0022] - modular implant assembled with two convex end modules, side sectional view;
[0023] - modular implant assembled with two concave end modules, side sectional view;
[0024] - modular implant assembled with convex and concave end modules, side view in section;
[0025] - variants of the end module with a convex surface formed by a sphere, general appearance;
[0026] - variants of the end module with a convex surface formed by a sphere, side view in section;
[0027] - variants of the end module with a concave surface formed by a sphere, general appearance;
[0028] - variants of the end module with a concave surface formed by a sphere, side view in section;
[0029] - intermediate module, general view;
[0030] - intermediate module, side view in section.
[0031] A modular cellular implant for replacing a circular defect in a long bone comprises a first end module, at least one intermediate module and a second end module; the first end module is made in the form of a monolithic, one-piece body equipped on one side with a surface intended for contact with the first bone fragment, made convex or concave spherical or conical, and on the opposite side with a surface intended for mating with the intermediate module; the second end module is made in the form of a monolithic, one-piece body equipped on one side with a surface intended for contact with the second bone fragment, made convex or concave spherical or conical, and on the opposite side with a surface intended for mating with the intermediate module;the intermediate module is made in the form of a monolithic, one-piece body equipped on opposite sides with surfaces intended for mating with the first and second end modules and / or other intermediate modules; each module is equipped with a through axial channel designed with the possibility of forming a common channel when connecting the modules for inserting an intramedullary fixator; the mating surfaces of the modules have a geometric shape that prevents rotation and lateral displacement of the modules relative to each other; the modules are made of a non-biodegradable material.
[0032] A modular cellular implant for replacing a circular defect of a long bone, characterized in that the module is made of titanium alloy VT-6.
[0033] A modular cellular implant for replacing a circular defect of a long bone, characterized in that the intermediate module is connected to the end modules by a protrusion-recess type connection.
[0034] A modular cellular implant for replacing a circular defect of a long bone, characterized in that the modules in axial section have a round, oval, triangular or rectangular shape with rounded edges, corresponding to the anatomical shape of the bone being replaced.
[0035] A modular cellular implant for replacing a circular defect of a long bone, characterized in that the modules have an external transverse dimension of 20 to 32 mm, the height of the end modules is 4 to 15 mm, the height of the intermediate module is 5 to 20 mm, that the axial channel is made with a diameter of 2 to 20 mm for fixation with an intramedullary rod, the surface of the modules has a roughness that ensures the adhesion of osteogenic cells and fixation of the bioactive coating.
[0036] A modular cellular implant for replacing a circular defect of a long bone, characterized in that the modules have a cellular structure and a bioactive coating, wherein the walls of the modules have a through cellular structure, and a bioactive coating selected from the group of hydroxyapatite, calcium phosphate coating, tricalcium phosphate, biphasic phosphate, deproteinized bone tissue, and / or an antibacterial coating selected from the group of silver, zinc, ofloxacin, gentamicin, tetracycline, cefazolin, cefotaxime, cefepime, vancomycin, amikacin, levofloxacin, meropenem, imipenem, tobramycin, sanguinarine hydrosulfate + chelerythrine hydrosulfate, linezolid, polymyxin B, colistin.
[0037] Example 1. A modular cellular implant for replacing a circular defect of a long bone contains a first end module 1, an intermediate module 2, and a second end module 3.
[0038] The first end module 1 is made in the form of a body equipped with a surface 4 intended for contact with the first bone fragment 5 and an opposite surface 6 intended for mating with the intermediate module 2.
[0039] The second end module 3 is made in the form of a body equipped with a surface 4 intended for contact with the second bone fragment 7 and an opposite surface 6 intended for mating with the intermediate module 2.
[0040] The intermediate module 2 is made in the form of a body equipped on opposite sides with surfaces 6 intended for mating with the first 1 and second 3 modules.
[0041] Each module 1, 2, and 3 is equipped with an axial channel 8, so that when modules 1 and 2, or 1 and 3, or 2 and 3, or 1 and 2 and 3 are connected, a common channel is formed. The mating surfaces 4 of the modules have a geometric shape that prevents lateral displacement of modules 1, 2, and 3 relative to each other.
[0042] Example 2A modular cellular implant for replacing a circular defect of a long bone () contains a first end module 1, three intermediate modules 2, and a second end module 3. The modules are made of titanium alloy VT-6.
[0043] The first end module 1 is made in the form of a body of revolution, with an outer diameter of 26 mm, equipped with a convex spherical surface 4 intended for contact with the first bone fragment 5 and an opposite surface 6 intended for mating with the intermediate module 2.
[0044] The second end module 3 is made in the form of a body of revolution, equipped with a convex spherical surface 4 intended for contact with the second bone fragment 7 and an opposite surface 6 intended for mating with the intermediate module 2. The height of the end modules is 10 mm.
[0045] The intermediate modules 2 are made in the form of bodies of revolution, equipped on opposite sides with surfaces 4 intended for connecting the intermediate modules with each other, as well as the outer intermediate modules with the first 1 and second 3 modules, through a connection of the protrusion 9 - recess 10 type. The height of the module is 5 mm.
[0046] Each module 1, 2, and 3 is equipped with an axial channel 8, so that when modules 1 and 2, or 1 and 3, or 2 and 3, or 1 and 2 and 3 are connected, a common channel is formed. The mating surfaces 4 of the modules have a geometric shape that prevents lateral displacement of modules 1, 2, and 3 relative to each other.
[0047] Example 3A modular cellular implant for replacing a circular defect of a long bone () contains a first end module 1, two intermediate modules 2, and a second end module 3. The modules are made of steel.
[0048] The first end module 1 is made in a square shape with rounded edges, the outer size is 22 mm, equipped at the end with a convex spherical surface 4 intended for contact with the first bone fragment 5 and an opposite surface 6 intended for mating with the intermediate module 2.
[0049] The second end module 3 is made in a square shape with rounded edges, the outer size is 22 mm, equipped with a conical surface 4 intended for contact with the second bone fragment 7 and an opposite surface 6 intended for mating with the intermediate module 2.
[0050] The intermediate modules 2 are made in the form of cylinders with an outer diameter of 22 mm, equipped on opposite sides with surfaces 6 intended for connecting the intermediate modules with each other and also with the first 1 and second 3 modules, through a connection of the protrusion 9 - recess 10 type. The height of the intermediate module is 10 mm.
[0051] Each module 1, 2, and 3 is equipped with an axial channel 8, so that when the modules are connected, a common channel is formed. The mating surfaces of the 4 modules have a geometric shape that prevents lateral displacement of modules 1, 2, and 3 relative to each other.
[0052] Example 4. Assembled modular implant with two convex end modules.
[0053] A modular cellular implant for replacing a circular defect of a long bone contains a first end module 1, one intermediate module 2, and a second end module 3. The modules are made of titanium alloy VT-6.
[0054] The first end module 1 is made in the form of a body of revolution, with an outer diameter of 26 mm, equipped with a convex spherical surface 4 intended for contact with the first bone fragment 5 and an opposite surface 6 intended for mating with the intermediate module 2.
[0055] The second end module 3 is made in the form of a body of revolution, equipped with a convex spherical surface 4 intended for contact with the second bone fragment 7 and an opposite surface 6 intended for mating with the intermediate module 2. The height of the end modules is 15 mm.
[0056] The intermediate modules 2 are made in the form of bodies of revolution, equipped on opposite sides with surfaces 6 intended for connecting the intermediate modules with each other, as well as the outer intermediate modules with the first 1 and second 3 modules, through a connection of the protrusion 9 - recess 10 type. The height of the intermediate module is 20 mm.
[0057] Each module 1,2,3 is equipped with an axial channel 8, so that when connecting the modules, a common channel 8 is formed. The mating surfaces of the 4 modules have a geometric shape that excludes transverse displacement of the modules 1,2,3 relative to each other.
[0058] Example 5. Assembled modular implant with two concave end modules.
[0059] A modular cellular implant for replacing a circular defect of a long bone contains a first end module 1, one intermediate module 2, and a second end module 3. The modules are made of titanium alloy VT-6 with a bioactive coating (bioactive coatings include calcium phosphate (tricalcium phosphate, hydroxyapatite, etc.) and fluorapatite ceramics).
[0060] The first end module 1 is made in the form of a circle, with an outer diameter of 32 mm, equipped with a concave spherical surface 4 intended for contact with the first bone fragment 5 and an opposite surface 6 intended for mating with the intermediate module 2.
[0061] The second end module 3 is made in the form of a body of revolution, equipped with a concave spherical surface 4 intended for contact with the second bone fragment 7 and an opposite surface 6 intended for mating with the intermediate module 2. The height of the end modules is 4 mm.
[0062] The intermediate modules 2 are formed as bodies of revolution, equipped on opposite sides with surfaces 6 designed to mate the intermediate modules with each other, as well as the outer intermediate modules with the first 1 and second 3 modules, via a protrusion-recess connection. The height of the intermediate module is 50 mm.
[0063] Each module 1,2,3 is equipped with an axial channel 8, so that when connecting the modules, a common channel 8 is formed. The mating surfaces of the 4 modules have a geometric shape that excludes transverse displacement of the modules 1,2,3 relative to each other.
[0064] Example 6. Assembled modular implant with convex and concave end modules.
[0065] A modular cellular implant for replacing a circular defect of a long bone contains a first end module 1, one intermediate module 2, and a second end module 3. The modules are made of titanium alloy VT-6 with a bioactive coating and a cellular structure (porous).
[0066] The first end module 1 is made with an outer diameter of 26 mm, equipped with a convex spherical surface 4 intended for contact with the first bone fragment 5 and an opposite surface 6 intended for mating with the intermediate module 2.
[0067] The second end module 3 is made with an outer diameter of 26 mm, equipped with a concave spherical surface 4 intended for contact with the second bone fragment 7 and an opposite surface 6 intended for mating with the intermediate module 2. The height of the end modules is 5 mm.
[0068] Intermediate module 2 has an outside diameter of 26 mm and is equipped with surfaces 6 on opposite sides designed to connect the intermediate modules to each other, as well as the outer intermediate modules to the first module 1 and second module 3, via a protrusion-recess connection. The height of the intermediate module is 5 mm.
[0069] Each module 1,2,3 is equipped with an axial channel 8, so that when connecting the modules, a common channel 8 is formed. The mating surfaces of the 4 modules have a geometric shape that excludes transverse displacement of the modules 1,2,3 relative to each other.
[0070] Implant modules can be made of titanium or its alloys using traditional metalworking technologies. Cellular implant modules can be made of titanium or its alloys using additive manufacturing, building up the material layer by layer.
[0071] The modular implant contains a universal set of components that allow for assembly to replace defects of various sizes (lengths) in any long bone. The implant has a central longitudinal channel (8 mm) designed for insertion of an intramedullary nail for fixation of the implant and bone. Adaptation of the bone-implant interface eliminates the need to trim the ends of the bone fragments to a strict 90° angle relative to the segment axis, which conserves bone tissue and eliminates the need for specialized instrumentation.
[0072] In specific variants, it is envisaged that in axial section the implant modules have a round, spherical, triangular, or rectangular shape corresponding to specific areas of certain bones.
[0073] The modules are designed to have an axial channel from 2 to 20 mm in diameter, which, when assembled, allows for the insertion of an intraosseous fixator in the form of nails, rods or pins.
[0074] The modules are designed to have a cellular structure with cell diameters ranging from 0.5 to 10 mm, allowing bone tissue to grow inward and outward and adhere tightly to the ends of bone fragments.
[0075] It is envisaged that the radius of the spherical surface of the end modules allows for the installation of a modular implant along the axis of the segment with the necessary correction without additional processing of the ends of the bone fragments.
[0076] The height of intermediate modules is provided to be from 3 to 50 mm.
[0077] It is envisaged that the outer diameter or the greatest distance between points in the axial section of modules with an oval or other shape is from 10 to 100 mm.
[0078] The implant is designed to have a rough surface for better fixation of the bioactive material and adhesion of osteogenic cells on the surface.
[0079] It is envisaged that the modules are covered with a bioactive layer, for example, hydroxyapatite.
[0080] It is envisaged that the modules are covered with a bioactive layer, for example, a calcium phosphate coating.
[0081] It is envisaged that the modules are covered with a bioactive layer, for example, tricalcium phosphate.
[0082] It is envisaged that the modules are covered with a bioactive layer, for example, biphasic phosphate.
[0083] It is envisaged that the modules are covered with a bioactive layer, for example, deproteinized bone tissue.
[0084] The modules are designed to be coated with a metal with antibacterial properties, such as silver.
[0085] The modules are designed to be coated with a metal with antibacterial properties, such as zinc.
[0086] It is assumed that layers of antibiotics in the form of ofloxacin and / or gentamicin and / or tetracycline and / or cefazolin and / or cefotaxime and / or cefepime and / or vancomycin and / or amikacin and / or levofloxacin and / or meropenem and / or imipenem and / or tobramycin and / or sanguinarine hydrogen sulfate + chelerythrine hydrogen sulfate and / or linezolid and / or polymyxin B and / or colistin can be applied to the surface of the modular implant.
[0087] It is envisaged that the implant can be fixed using the Ilizarov apparatus or another external fixation device. It is envisaged that the implant-bone system can be fixed using an intramedullary nail. Using an implant.
[0088] Replacement of a circular defect of a long bone using a modular implant, which allows for the extension of the implant length depending on the extent of the defect and a modular implant.
[0089] During surgery, the implant is assembled from modules 1, 2, and 3 (), (), (), (), (), (). After resection and adaptation of the bone fragment ends, this allows for the restoration of circular bone defects of various sizes and any etiology, providing stable fixation, optimizing osteogenesis, preventing inflammation, and even treating osteomyelitis. The implant set consists of end modules 1 and 3 and intermediate modules 2. End modules 1 and 3, on the side adjacent to the bone, feature a convex or concave spherical surface 4.
[0090] On the other side, there is a joint for connecting to an intermediate module or to each other. The intermediate modules also have joints at their ends for connecting to each other or to the end modules. The joint ensures tight contact between the modules, preventing any relative movement.
[0091] The design features allow for bone defect replacement and stability between modules, ensuring a tight fit between the implant and the ends of the bone fragments. The axial channel allows for fixation with an intramedullary nail (11), creating compression in the implant-bone interface. The bioactive coating, roughness of the modules, and the cellular structure optimize osteogenesis and angiogenesis in the implant area, resulting in consolidation.
[0092] The end modules 1 and 3 on the side adjacent to the bone are represented by a convex or concave spherical surface 4 (conical or spherical); on the other side there is a node for connecting 4 with the intermediate module 2 or with each other.
[0093] The intermediate modules 2 also have nodes 4 on both sides for connecting them to each other or to the end modules 1 and 3. The connection node 4 ensures tight contact between the modules, preventing displacement relative to each other. Along the longitudinal axis of the modules, there is a channel 8 for inserting an intramedullary nail 11 for fixation.
[0094] The modular implant design, without the time-consuming manufacturing of a customized product, allows for the replacement of circular bone defects of various sizes and any etiology. Stable implant-bone contact is achieved through both intraosseous and transosseous osteosynthesis, while simultaneously optimizing osteogenesis and enabling effective intervention against the infectious agent.
[0095] Industrial applicability. Clinical example 1. A 56-year-old patient presented with a post-traumatic defect—diastasis of the left tibia shaft—of 1 cm with incongruent fragment ends. There were no local signs of inflammation.
[0096] During surgery, the defect was accessed and the ends of the bone fragments were adapted for the implant, partially resected. One end of the bone fragment was shaped convex, while the other was concave, to preserve bone mass. A modular honeycomb implant was inserted to fill the circular defect of the long bone. It contained end module 1 with a convex sphere, end module 3 with a concave sphere, and intermediate module 2.
[0097] End module 1, a convex spherical module, has a convex surface 4 at one end and a coupling node 6 at the other. End module 3 has a concave surface 6 and a coupling node 4. Intermediate module 2 has a coupling node 4 at both ends. An axial channel 8 is formed along the central axis of the modules. The modules are circular in cross-section and have an outer diameter of 26 mm. The height of end modules 1 and 2 is 5 mm, and the intermediate module is 10 mm. The module cells are 3 mm in size. A calcium phosphate layer is formed on the implant surface.
[0098] After implant placement, the medullary canal was opened in one-third of the tibia and reamed. Using a special instrument included in the intramedullary nail kit, the nail was inserted, axial compression was created, and locking was performed.
[0099] The design features allowed for the closure of a 1-cm bone defect and the achievement of intermodular stability, ensuring a tight fit between the implant and the ends of the bone fragments. The presence of an axial channel allowed for fixation with an intramedullary nail, creating compression in the implant-bone interface. The bioactive coating, the roughness of the modules, and the cellular structure optimized osteogenesis and angiogenesis in the implant area, resulting in consolidation.
[0100] Case Study 2. A 36-year-old patient presented with an open comminuted fracture of the tibia. Primary surgical debridement of the wound and skeletal traction were performed for 2 weeks. After accessing the tibial fragments, the loose fragments were removed and the ends of the tibial fragments were adapted to the sphericity of the implant. The diastasis between the fragments was 4 cm. A modular honeycomb implant was inserted to fill the circular defect of the long bone. It contained two end modules (1 and 3) with a convex sphere and two intermediate modules (2). Intermediate module (2) has a coupling node (4) at both ends.
[0101] An axial channel 8 is formed along the central axis of the modules. The first module, with a convex sphere 1, is circular in cross-section and has an outer diameter of 24 mm and a height of 10 mm. The intermediate module 2 is circular in cross-section with an outer diameter of 24 mm and a height of 10 mm. The second end module, with a convex sphere 1, is triangular in cross-section with a maximum distance along the outer edge of 28 mm and a height of 10 mm. The module cells are 4 mm in diameter. A calcium phosphate layer containing an antibacterial agent is formed on the implant surface.
[0102] After implant placement, a canal was opened in the first third of the tibia and reamed. Using a special instrument included in the intramedullary nail kit, the nail was inserted, axial compression was created, and locking was performed.
[0103] The design features allowed for the closure of a 4-cm bone defect and achieved stability between the modules, ensuring a tight fit between the implant and the ends of the bone fragments. The presence of an axial channel allowed for fixation with an intramedullary nail, creating compression at the implant-bone interface. The bioactive coating, the roughness of the modules, and the cellular structure optimized osteogenesis and angiogenesis in the implant area, resulting in consolidation. The antibacterial coating, in turn, prevented the development of infection.
[0104] Case Study 3. A 42-year-old female patient with a diagnosis of chronic posttraumatic osteomyelitis of the femur was in remission. Eight weeks prior to admission, an osteonecrectomy with placement of a temporary antibacterial cement spacer was performed. Bacteriological examination of the peri-implant puncture revealed no pathogen. A complete blood count and C-reactive protein level confirmed the infectious process was in remission.
[0105] In the operating room, the cement spacer was removed, and the ends of the fragments were adapted for the implant. The diastasis between the fragments was 6 cm. A modular honeycomb implant was installed to replace a circular defect of the long bone. It contains two end modules 1 and 3 with a concave sphere and five intermediate modules 2. End modules 1 and 3 have a concave sphere 4 at one end and a mating surface 4 at the other. Intermediate modules 2 have mating nodes 4 at both ends. The first module with a concave sphere in oval cross-section has a largest outer diameter of 40 mm and a height of 5 mm. Intermediate modules 3 have an oval cross-section with a largest outer diameter of 40 mm and a height of 10 mm. The second module with a concave sphere in oval cross-section has a largest diameter of 40 mm and a height of 5 mm. A calcium phosphate layer containing an antibacterial agent is formed on the surface of the implant.
[0106] Fixation was performed using the Ilizarov apparatus due to a history of osteomyelitis.
[0107] The design features allowed for the 6-cm bone defect to be bridged and stability to be achieved between the modules, ensuring a tight fit between the implant and the ends of the bone fragments. Fixation was achieved through transosseous osteosynthesis using the Ilizarov apparatus, creating the necessary compression at the implant-bone interface. The bioactive coating, the roughness of the modules, and the cellular structure optimized osteogenesis, angiogenesis, and complete osseointegration of the implant. The antibacterial coating, in turn, prevented recurrence of osteomyelitis.
[0108] first end module (1);
[0109] intermediate module (2);
[0110] second end module (3);
[0111] bone mating surface (4);
[0112] first bone fragment (5);
[0113] module mating surface (6);
[0114] second bone fragment (7);
[0115] axial channel (8);
[0116] ledge (9);
[0117] cavity (10);
[0118] intramedullary nail (11).
Claims
A modular cellular implant for replacing a circular defect of a long bone, characterized in that it contains a first end module, at least one intermediate module and a second end module; the first end module is made in the form of a body equipped on one side with a surface intended for contact with the first bone fragment, made convex or concave spherical or conical, and on the opposite side with a surface intended for mating with the intermediate module; the second end module is made in the form of a body equipped on one side with a surface intended for contact with the second bone fragment, made convex or concave spherical or conical, and on the opposite side with a surface intended for mating with the intermediate module;the intermediate module is made in the form of a body equipped on opposite sides with surfaces intended for mating with the first and second end modules and / or intermediate modules; each module is equipped with a through axial channel made with the possibility of forming a common channel when connecting the modules for inserting an intramedullary fixator; the mating surfaces of the modules have a geometric shape that excludes transverse displacement of the modules relative to each other; the modules are made of a non-biodegradable metallic material possessing biocompatibility, selected from: titanium or its alloy, for example from the VT-6 alloy or from a steel material. A modular cellular implant according to paragraph 1, characterized in that the intermediate module is connected to the end modules by a protrusion-recess type connection. A modular cellular implant according to paragraph 1, characterized in that the modules in axial section have a round, oval, triangular or rectangular shape with rounded edges, corresponding to the anatomical shape of the bone being replaced. A modular cellular implant according to paragraph 1, characterized in that the modules have an external transverse dimension from 20 to 32 mm, the height of the end modules is from 4 to 15 mm, the height of the intermediate module is from 5 to 20 mm, that the axial channel is made with a diameter from 2 to 20 mm for fixation with an intramedullary rod, the surface of the modules has a roughness that ensures the adhesion of osteogenic cells and fixation of the bioactive coating. A modular cellular implant according to claim 1, characterized in that the modules have a cellular structure and a bioactive coating, wherein a bioactive coating selected from the group of hydroxyapatite, calcium phosphate coating, tricalcium phosphate, biphasic phosphate, deproteinized bone tissue, and / or an antibacterial coating selected from the group of silver, zinc, ofloxacin, gentamicin, tetracycline, cefazolin, cefotaxime, cefepime, vancomycin, amikacin, levofloxacin, meropenem, imipenem, tobramycin, sanguinarine hydrosulfate + chelerythrine hydrosulfate, linezolid, polymyxin B, colistin is applied to the surface of the modules.
